No profile data available.
Talphera, Inc. (TLPH) is a healthcare company in the targeted healthcare equipment industry, based in San Mateo, United States, with about 12 full-time employees.
It reported revenue of $28,000 for fiscal year 2025, and net income of -$14.29 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0, down 100.0% from a year before. Its market capitalization was $56.06 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit.
Talphera reported $28,000 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$56.06 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Daxor Corporation (DXR), Medinotec Inc. (MDNC), Fractyl Health, Inc. (GUTS), Sensus Healthcare, Inc. (SRTS).